Black Pepper and the Endocannabinoid System (ECS)

December 29, 2015

Black pepper contains beta-caryophyllene (BCP). BCP is a cannabinoid that acts specifically on the body’s CB2 cannabinoid pathways within the ECS. The ECS is a homeostatic regulator of inflammation throughout the human body.

 

BCP is also found in essential oils of a variety of plants, including rosemary, hops, cloves, and cannabis. BCP is also a major component (up to 35%) in the essential oil of Cannabis sativa

 

The CB2 receptor of the ECS has been shown to be a promising target for combating inflammatory based diseases. Inflammatory diseases ranging from MS to epilepsy and arthritis have been shown to be impacted in a positive way through activation of the CB2 receptor by cannabinoids.

 

BCP has been shown to competitively bind to the CB2 receptor THC binding site. Although THC has a high affinity for CB1 binding, it does bind to CB2 as well, with less affinity. CB1 receptors are predominantly located in the brain and CB2 is predominantly located in the immune system.

 

BCP has also been shown to inhibit TNF (tumor necrosis factor). TNF refers to a group of cytokines that can cause tumor cell death. Drugs that block the action of TNF have been shown to be beneficial in reducing the inflammation in inflammatory diseases such as Crohn's disease and rheumatoid arthritis.

 

So how can it be beneficial to block TNF if it kills cancer cells? There is something called a cytokine storm that can occur when pro-inflammatory compounds are activated, such as in TNF. Not all inflammation is bad. However, when the inflammation can't be stopped, as in a cytokine storm, the collateral damage to the surrounding cells can be catastrophic, resulting in sepsis and possibly death.

 

Therefore, black pepper should be involved in as many meals as possible. Be sure to use fresh peppercorn as black pepper is known to lose potency after being cracked. Ground black pepper loses its potency after a few hours.

 

 

 

Please reload

Featured Posts

Cannabis Treats Brain Cancer Effectively in FDA Trial for Humans

February 9, 2017

1/5
Please reload

Recent Posts
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Classic
  • Twitter Classic
  • Google Classic

CONTACT FOR A FREE CONSULTATION

Loren DeFalco, President

loren@the-ECS.com

 

Follow me:

  • Twitter Clean
  • w-blogger
RSS Feed

© 2015 by The ECS Solution

The content on theecs.com including but not limited to text, graphics, images, RSS feeds, links and all other material contained on the website is intended for your general knowledge and education only and is NOT a substitute for medical advice or treatment for a specific medical condition.

Any information contained on www.the-ecs.com is not intended to diagnose, prevent, treat or cure any disease.

In no way are you to consider the information I offer as medical advice, nor does it constitute a doctor/patient relationship.

Never disregard professional medical advice or delay in seeking it because of something you have read on www.the-ecs.com or any other website(s) linked to it.